Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Resistance training might help with PCOS symptoms, but more research is needed.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Hair loss in women not always linked to increased oil production; other factors may be involved.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.